A critical research goal is to identify modifiable risk factors leading to functional disabilities in young psychiatric patients. The authors developed a multidimensional trans-diagnostic predictive model of functional outcome in patients with the recent-onset of a psychiatric illness. Baseline clinical, psychosis-risk status, cognitive, neurological-soft-signs measures, and dopamine-related-gene polymorphisms (DRD1-rs4532, COMT-rs165599, and DRD4-rs1800955) were collected in 138 young non-psychotic outpatients. 116 individuals underwent follow-up (mean=2.2 years, SD=0.9) examination. A binary logistic model was used to predict low-functioning at follow-up as defined by a score lower than 65 in the social occupational functioning assessment scale. A total of 54% of patients experiences low functioning at follow-up. Attention, Avolition, and Motor-Coordination subscale were significant predictors of low-functioning with an accuracy of 79.7%. A non-significant trend was found for a dopamine-related-gene polymorphism (DRD1-rs4532). The model was independent of psychotic-risk status, DSM-diagnosis, and psychotic conversion. A trans-diagnostic approach taking into account specific neurocognitive, clinical, and neurological information has the potential to identify those individuals with low-functioning independent of DSM diagnosis or the level of psychosis-risk. Specific early interventions targeting modifiable risk factors and emphasize functional recovery in young psychiatric samples, independent of DSM-diagnosis and psychosis-risk, are essential.
Introduction
Functional disabilities are common among mental disorders (Kessler et al., 2009) . Even though psychotic spectrum disorders (PSDs) (Lee et al., 2015) are traditionally associated with greater functional disability than affective and anxiety disorders (Plaisier et al., 2010) , a 2009 update from the World Mental Health Survey shows that severe functional impairments are not unique to the psychosis-spectrum (Kessler et al., 2009) . A critical research goal is therefore to identify and intervene to target modifiable risk factors leading to long-term disability not only in PSDs, but in the whole spectrum of psychiatric disorders (Lee et al., 2015) .
Studies of adults with chronic mental illness show that multiple factors are linked to functional decline across traditional diagnostic boundaries (Iosifescu, 2012) . Baseline impairments in functioning (Carrión et al., 2013) , cognition and theory of mind (Lee et al., 2015) , as well as neurological, neurophysiological and brain structural abnormalities (Dazzan & Murray, 2002) , have been associated with future poor functional outcomes in schizophrenia (Chan et al., 2015) , mood , anxiety , and personality disorders (Plaisier et al., 2010; Dazzan & Murray, 2002) .
Findings in adult populations are often tempered by chronic illness and prolonged treatment (Allott et al., 2011) . Research efforts targeting functional recovery should thus be focused on the earlier phases of psychiatric disorders, when individuals are less impaired and more amenable to therapeutic interventions (Fusar-Poli et al., 2014) .
So far, most studies investigating functional outcome in early-onset psychiatric syndromes pertain to individuals with an "At-Risk Mental State" (ARMS) for psychosis (Carrión et al., 2013) . Approximately 1/3 of ARMS individuals develops a psychotic episode (Fusar-Poli et al., 2014) . However, many of them remain functionally impaired independently of psychosis transition, highlighting the need for a broad, trans-diagnostic approach to functional outcome, cutting across the psychotic spectrum (Carrión et al., 2013) .
Given the relevance of functional outcome in psychiatry, and the evidence that disability is not unique to psychotic disorders (Kessler et al., 2009; Lee et al., 2015) , research on early predictors of functional decline should target the full range of recent-onset psychiatric syndromes.
Specifically: negative and disorganized symptoms, neurological soft signs, theory of mind, neurocognition, and baseline functioning abnormalities have been consistently detected in young psychiatric outpatients and related to future outcomes independent of DSM diagnosis and psychosis-risk status (Lee et al., 2015; Plaisier et al., 2010; Iosifescu, 2012; Francesconi et al., 2016a; Minichino et al., 2016a) . These domains may represent optimal trans-categorical predictors of functioning and thus new promising therapeutic targets. Some of these domains, such as neurocognitive and theory of mind impairments, seem to be linked to functional disability regardless of the expression of symptoms Lee et al., 2015) , as they are also expressed in the unaffected relatives of patients with mental illness (Tsang et al., 2015) . These findings suggest that genetic factors could contribute to future outcome (Tsang et al., 2015) possibly as a mediating variable. Several susceptibility genes are associated with cellular mechanisms linked to cognitive processing domains that are predictors of functional outcome in ARMS studies (Plaisier et al., 2010) . In particular, dopamine-related gene polymorphisms associated with dopaminergic function in prefrontal cortex, such as the Dopamine Receptor D1 (DRD1) rs4532, the Catechol-O-Methyltransferase (COMT) rs165599, and the Dopamine Receptor D4 (DRD4) rs1800955, have been linked to specific cognitive impairments (e.g. verbal fluency and working memory), in both relatives and patients across different diagnostic groups (Tsang et al., 2015) .
The present study aimed to identify trans-diagnostic baseline predictors of low functional outcome, consistent with the Research Domain Criteria initiative from the National Institute of Mental Health (Cuthbert & Insel, 2013) , in a large, prospective, longitudinal sample of helpseeking adolescents and young adults treated in secondary mental health services.
We addressed the following questions: (A) What are the functional trajectories of young patients with a recent-onset psychiatric disorder with 2 to 3 years of follow-up? (B) How are baseline functioning, cognition, theory of mind, genetic and neurological variables associated with long term functioning in these individuals? (C) Is prediction of functional outcome independent of (i) ARMS status; (ii) psychosis transition; and (iii) psychiatric diagnosis?
Methods
The institutional review board of Sapienza, University of Rome approved the study. Written informed consent (with assent from participants <18) was obtained from all participants.
Participants and recruitment strategy
Subjects were recruited in three different clinics (Rome, Italy) that provide secondary general mental health care for adolescents and young adults. Recruitment strategy and inclusion/exclusion criteria are given in eAppendix and in previously published studies Francesconi et al., 2016b; Minichino et al., 2016a) .
Baseline assessment
Clinical information was obtained through the SCID-I and II and the Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1987) . The Comprehensive Assessment of At-Risk Mental States (CAARMS) interview was used to identify (Yung et al., 2005) ARMS+ and ARMSindividuals. The CAARMS inter-rater reliability was assessed in 34 subjects (ICC=0.93). NSS were assessed with the Neurological Evaluation Scale (NES) (Buchanan & Heinrichs, 1989) , which comprises the following subscales: "sensory-integration", "motor-coordination", "sequencing of complex motor acts", and "others". Neurocognition was assessed with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) (Randolph et al. 1998 ). The RBANS comprises five index scores (Attention, Immediate and Delayed Memory, Language and Visuospatial indices) and a total score. Social cognitive ability was assessed using the following scales: the Reading the Mind in the Eye Test (Baron-Cohen et al., 1997) , the Faux Pas (Stone et al., 1998) test and the Theory of Mind Assessment Scale (Bosco et al., 2009) .
Baseline Functioning was assessed using the Global Assessment of Functioning scale (GAF) (Hall, 1995) , the Social and Occupational Functioning Assessment Scale (SOFAS) (Yung et al., 2005) , and the Life Skills Profile-39 items (Rosen et al., 1989) . The LSP-39 comprises 39 items grouped in 5 subscales: Self-Care, Responsibility, Communication, Non-Turbulence, and Socialcontact. A total score can be obtained by summing the responses for all items with low scores reflecting high level of skills. The LSP-39 total score has been consistently used as a proxy of real-word living skills (Puig et al., 2013) .
Genetic
Using salivary samples, the DRD1 rs4532 (-48A/G), the COMT rs165599 and the DRD4 rs1800955 (C-521T) polymorphisms were evaluated in a subgroup of participants (n=74) (see eAppendix).
Follow-up procedure
Functional and clinical data were collected through a single follow-up face to face interview that took place at a mean time of 2.2 years from the baseline assessment. Transition to psychosis was defined according to previously operationalized criteria (Yung et al., 2005) .
Functional outcome
The primary outcome variable for this study was functional outcome at the follow-up visit as defined by the SOFAS.
This scale was used given its wide clinical and consistent use as primary measures of functional outcome in several studies and meta-analyses on ARMS individuals (Cotter et al., 2014; Fusar-Poli et al., 2015) , thus potentially facilitating interpretation of findings and future replication studies.
The overall sample was divided in two groups: Low Functional (LF) and High functional (HF) outcome.
LF and HF were defined as a current score of 65 and higher (HF) or 64 and lower (LF) in the SOFAS during the follow-up examination.
The group split at SOFAS score of 65 was chosen according to previously published methods (Allen et al., 2015) . The 60-70 range corresponds to the presence of "some difficulty in social or occupational functioning but [the subject] generally functions pretty well". SOFAS scores below 60 indicate "moderate to severe impairment", whilst sores above 70 correspond to "slight impairment to good function". Also, 65 was the median SOFAS value for the overall sample during the follow-up assessment.
An additional measure of functional outcome, as defined by the LSP-39 total score was also collected at follow-up.
Statistical analysis
All analyses were conducted using SPSS version 21.0. Comparison of baseline characteristics was performed with ANOVAs for continuous variables and Pearson χ 2 tests for categorical variables (2-tailed, P<0.05). A binary logistic model was constructed to predict functional outcome according to the SOFASbased definition of functioning at follow-up.
Based on previous evidence, predictor variables were generated within the following domains: demographic and clinical (Addington et al., 2015) , neurocognitive (Meyer et al., 2014) , theory of mind (Lee et al., 2014) , NSS (Chan et al., 2009 ) and functioning at baseline (Carrion et al., 2013) (eTable1), and selected in several steps (Hosmer et al., 2013; Carrion et al., 2013) 
The final models were adjusted for the possible confounding effects of (i) psychosis transition at follow-up; (ii) ARMS status; (iii) DSM-IV diagnosis at baseline; (iv) PANSS general subscale score at baseline; (v) antipsychotic and psychotherapy intervention at baseline and follow-up;
and (vi) drug/alcohol abuse at follow-up.
Results

Participants
A total of 140 participants were referred to the study. Two individuals fulfilled SCID-I criteria for substance abuse, and were excluded. The remaining 138 individuals underwent CAARMS interview. A total of 67 ARMS+ and 71 ARMS-were enrolled in the study.
Of the 138 subjects enrolled in the study, 22 (15.9%) were lost and 116 (84.1%) completed the follow-up clinical evaluation, (Figure 1) . Patients with follow-up information did not differ significantly from those lost to follow-up in any of the variables investigated. Table 1 shows demographic, clinical, cognitive and NSS information of the HF and LF groups.
At baseline, the LF group had a higher prevalence of comorbid anxiety and mood disorders compared to the HF. Negative symptoms and functional impairments at baseline were significantly greater in the LF group, which was also characterized by a higher transition to psychosis rate at follow-up (Table 1) . Of note, the proportion of individuals who met ARMS criteria did not differ between the HF and LF groups.
During the follow-up period, there was a significant difference in the percentage of change in functioning between the two outcome groups. Patients in the HF group showed an improvement in SOFAS and LSP-39 total score (+12% and +7%, respectively), while the LF group showed a relevant functional decline (-21% and -17%).
At baseline, significantly lower scores on the RBANS Attention, Immediate Memory and Delayed Memory indices were found in LF individuals, as well as higher levels of motorcoordination signs ( Table 1) .
Correlation among measures of functional outcome at follow-up
Compared to the HF group, the LF group showed significantly lower scores in the follow-up LSP-39 total scores (Table 1) .
At follow-up, SOFAS scores were significantly correlated with LSP-39 total scores (r=-0.57: P=<0.001). Table 1 reports baseline and follow-up medications of the HF and LF groups. At follow-up, the percentage of patients in the LF group receiving antipsychotics (P<0.01), mood stabilizers (P<0.05) anxiolytics (P<0.05), and psychotherapy (p<0.01) was significantly higher than at baseline. The HF group, as well, received more antipsychotics (P<0.01) and psychotherapy (P<0.01) compared to baseline. These data indicate active therapeutic interventions during the follow-up period in both LF and HF individuals. Finally, 13.8% of the sample developed a drug dependence/abuse diagnosis at follow-up (P<0.01), but no differences were found between HF and LF.
Treatment
Prediction of Functional outcome
The RBANS Attention Index, the CAARMS Avolition item, and the NSS Motor-Coordination subscale were significant predictors of LF outcome ( Table 2) . The final multivariable model accounted for 35% of the variance (R 2 N=0.350) and showed a good discriminative ability, with an AUC of 79.7% (95% CI, 71.7-87.8; P<.001), a sensitivity of 73.0% and specificity of 67.9% (eFigure1).
Prediction of functional outcome in a subgroup of individuals (n=74) with the analyzable genetics data Table 1 shows the prevalence of the DRD1 rs4532, COMT rs165599 and DRD4 rs1800955 polymorphisms in the subgroup of patients with analyzable data (n=74). There were no significant differences between LF and HF groups in terms of expression of COMT rs165599 and DRD4 rs1800955 polymorphisms. In contrast, the AG and GG genotypes of the DRD1 rs4532 were significantly more expressed in the LF than in the HF group (P<0.05) ( Table 1) .
The "presence of the G allele (DRD1)" (i.e. expression of the AG or GG genotype) was thus added to the set of three variables previously identified, with the aim of evaluating whether genetic data could improve the final predictive model of functional outcome.
Given the smaller number of participants (n=74) available for this analysis, we decided to report also non-significant statistical trend results (P<0.10) for the final step of the regression.
We used this approach, even if limited by this liberal threshold, because it could represent a relevant hypothesis-generating finding. Indeed: 1) there is a lack of studies investigating the impact of clinical-genetic interactions on prognostic outcomes in psychiatry; and 2) given the young age and the relatively short duration of illness characterizing our sample, our findings may be useful for future studies investigating early modifiable risk factors of functional disabilities.
Using this approach, the Attention Index, Avolition and "presence of the G allele (DRD1)"
predicted LF with an accuracy of 81.9% (Table 3) In both the multivariable models (with and without genetic findings), the identified predictive variables continued to predict functional outcome even after adjusting for potential confounding variables (eTable2), including ARMS status, ultimate conversion status, and DSM-IV diagnosis.
The Attention Index, Avolition and "presence of the G allele (DRD1)" were significant predictors of LF ( Table 3 ). The final model accounted for 39% of the variance (R 2 N = 0.394).
The overall predictive ability of this model was higher compared to the previous one, with an AUC of 81.9% (95% CI, 72.6-91.3; P<0.001; eFigure 2), a sensitivity of 75.6% and specificity of 72.7%. In both the multivariable models, the identified predictive variables continued to predict functional outcome even after adjusting for potential confounding variables (eTable2),
including ARMS status, ultimate conversion status, and DSM-IV diagnosis.
Similar results were obtained with an alternative multivariable model built using the LSP-39 total score as primary measure of functional outcome at follow-up (eModels).
Discussion
To the best of our knowledge, this is the first study using a broad trans-diagnostic approach, to identify predictors of functional outcome across recent onset psychiatric syndromes. Our sample was composed of individuals who came to a youth mental health clinic for treatment, did not meet criteria for a psychotic disorder and had different levels of risk for psychosis. In contrast to other ARMS samples, our participants were already diagnosed and treated for specific psychiatric disorders, with mean illness duration of 2.1 years, suggesting greater and more stable psychopathological severity. Our study yielded 4 relevant findings. First, 48% of the patients were ARMS+, however, low functional outcome was independent of ARMS classification and DSM-IV diagnosis. This confirms previous findings that baseline positive symptoms are not predictive of low functional outcome (Carrion et al., 2013) , and suggests that categorizing patients based on traditional classification systems is not informative in regards to functional trajectories. Second, NSS, neurocognitive performance and negative symptoms at baseline were key predictors of LF during the early phases of different psychiatric syndromes. Third, a genetic marker improved the predictive model, suggesting that genetic markers may also have a relevant impact on functional outcome. Fourth, LF was not entirely dependent on the development of psychosis, further promoting the need for a broader trans-diagnostic approach in the field of functional recovery Minichino et al., 2016b; Lee et al., 2015) .
Patients in the LF group showed baseline impairments on the RBANS Attention, Immediate and Delayed indices, with Attention being a significant predictor of functional outcome. Previous evidence suggests that these indices assess similar constructs as more widely used neurocognitive batteries (Hobart et al., 1999) . Poor performance on the RBANS Attention index has been shown to be associated with global functioning in cohorts of chronic psychiatric patients independent of the diagnosis (Carrion et al., 2013) . The Attention index, composed of a Digit span and a Coding task (Hobart et al., 1999) , is a combined measure of processing speed and working memory (Nuechterlein et al., 2004) . In a real-word context, reduced reaction time and an impaired ability to maintain and process information might affect global functioning, for example reducing the ability to select and maintain conversational topics (Dickinson et al., 2007) .
The LF group was also characterized by higher levels of negative symptoms, with Avolition being an independent predictor of functional outcome. Negative symptoms have traditionally been associated with schizophrenia spectrum disorders (Norman et al., 2015) . However, a growing body of evidence suggests that they are expressed in association with LF across different psychiatric diagnoses . Thus, it is not surprising that Avolition may represent a predictor of functional outcome independent of the ARMS status and DSM-IV diagnosis.
Greater motor-coordination abnormalities also made a significant independent contribution to the prediction of functional outcome. These results are consistent with a recent study by Mittal and colleagues (Mittal et al., 2014) , which provides evidence for a role of NSS in predicting poor outcomes in ARMS individuals independent of psychosis transition. The authors also showed that NSS predicted a longitudinal decrease in the white matter integrity of the cerebello-thalamic tract that was associated with higher levels of negative symptoms. Consistent with the transdiagnostic approach used in the current study, high levels of NSS have been associated with specific neural network abnormalities, cognitive dysfunction, negative symptoms and low functioning in both psychotic and non-psychotic individuals Dazzan & Murray, 2002) .
The expression of NSS, neurocognitive deficits, and negative symptoms can be related to overlapping brain structural and functional connectivity changes (Mittal et al., 2014) , such as fronto-parietal (Chan et al., 2009 ) and cerebello-thalamo-prefrontal dysfunctions (Zhao et al., 2014; Minichino et al., 2014) . Consistently, the LF group showed a higher prevalence of the G allele, which also showed a non-significant trend in prediction of functional outcome in a subgroup of patients.
The -48A/G polymorphism is associated with a reduced binding ability of DRD1 in the prefrontal cortex (PFC) (Baulieu & Gainetdinov, 2011) , and with a reduced PFC activation during cognitive tasks (Williams & Goldman-Rakic, 1992) . Dysfunctions of DRD1 signaling in the PFC have been proposed as a potential cause of NSS (Russel et al., 2005) , negative symptoms (Lynch, 1992) and neurocognitive deficits (Tsang et al., 2015) in both schizophrenia (Goldman-Rakic et al., 2004) and non-schizophrenia spectrum disorders (Tsang et al., 2015) .
Furthermore, evidence suggests that the DRD1 polymorphism may lead to antipsychotic resistance independent of the psychiatric diagnosis (Ota et al., 2012) . It is possible that LF at follow-up could be associated with the expression of the G allele and thus with treatment resistance. This finding highlights the need for more targeted pro-cognitive intervention in patients with low functional trajectories.
The reduced binding ability of the DRD1 in the PFC may trigger a cascade of events leading to (i) NSS abnormalities; (ii) neurocognitive impairments; (iii) greater levels of negative symptoms;
and (iv) antipsychotics resistance, defining the common thread that characterizes those individuals with low functional outcome across diagnostic categories. As previously highlighted, motor-coordination signs, processing speed and working memory deficits, as well as severity of negative symptoms, have been related to shared neural vulnerabilities, mainly involving the cerebello-thalamo-prefrontal network (Mittal et al., 2014; Zhao et al., 2014) , which is rich in DRD1 receptors. Young patients expressing these characteristics may benefit from specific interventions based on plasticity-based trainings or non-invasive brain modulation techniques targeting this network (Minichino et al., 2015) . These non-pharmacological strategies may be particularly helpful in patients expressing the DRD1-rs4532 polymorphism, given its association with antipsychotics resistance.
In conclusion, greater attention should be given to functional outcomes in patients with a recent onset psychiatric disorder even if they are not considered at risk for transition to psychosis. In secondary mental health services, a trans-diagnostic approach that takes into account specific neurocognitive, clinical and neurological dimensions, has the potential to identify those patients with a common functional trajectory, despite the clinical heterogeneity. While future studies with larger sample sizes are needed in order to draw definitive conclusions, our results provide useful information on a young psychiatric sample, in which specific therapeutic interventions have the potential to significantly limit functional disability.
Strengths and Limitations
Developing site-specific predictor profiles, as proposed here, has a number of limitations, the need for cross-validation being a primary one. Second, norms for the RBANS in children and adolescents are not yet available. Hence, consistent with previous evidence (Holzer et al., 2007) , the raw scores in this study were scaled using the norms for 20-39 year olds also for all participants aged 17-19. Given the short administration time and its reliability, the RBANS represents an interesting screening tool compared to more time-consuming cognitive assessment batteries. Third, our ARMS+ detection rate is higher compared to those reported by previous studies (Rietdijk et al., 2012) . However, it is still consistent with evidence suggesting that: (i) a consecutive screening in a secondary mental health facility detects more ARMS+ than a referral at suspicion strategy (54) and (ii) greater and more stable general psychopathology is associated with a reduction in ARMS false positives and a higher detection rate (Rietdijk et al., 2012) .
Similarly, the rate of psychotic conversion in the identified ARMS sample (25.4%) is consistent with previously published rates of conversion over a 1-2.5 year time period (Cornblatt et al., 2003) . The AUC values can range from 0.5 (indicates that an instrument can discriminate between groups no better than chance) to 1.0 (represents perfect discriminatory performance) and can be interpreted using the following categories: acceptable = 0.70, good = 0.80, and excellent = 0.90. The AUC values can range from 0.5 (indicates that an instrument can discriminate between groups no better than chance) to 1.0 (represents perfect discriminatory performance) and can be interpreted using the following categories: acceptable = 0.70, good = 0.80, and excellent = 0.90. 
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